Northwestern Mutual Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.29M | Buy |
7,046
+462
| +7% | +$85.1K | ﹤0.01% | 1252 |
|
|
2025
Q4 | $1.16M | Buy |
6,584
+654
| +11% | +$107K | ﹤0.01% | 1244 |
|
|
2025
Q3 | $831K | Buy |
5,930
+127
| +2% | +$17.2K | ﹤0.01% | 1296 |
|
|
2025
Q2 | $729K | Buy |
5,803
+271
| +5% | +$33.8K | ﹤0.01% | 1260 |
|
|
2025
Q1 | $757K | Buy |
5,532
+177
| +3% | +$25.3K | ﹤0.01% | 1193 |
|
|
2024
Q4 | $819K | Sell |
5,355
-1,314
| -20% | -$222K | ﹤0.01% | 1135 |
|
|
2024
Q3 | $1.29M | Sell |
6,669
-640
| -9% | -$134K | ﹤0.01% | 978 |
|
|
2024
Q2 | $1.69M | Buy |
7,309
+543
| +8% | +$118K | ﹤0.01% | 866 |
|
|
2024
Q1 | $1.46M | Sell |
6,766
-548
| -7% | -$128K | ﹤0.01% | 886 |
|
|
2023
Q4 | $1.89M | Buy |
7,314
+134
| +2% | +$32.9K | ﹤0.01% | 783 |
|
|
2023
Q3 | $1.85M | Sell |
7,180
-1,922
| -21% | -$514K | ﹤0.01% | 749 |
|
|
2023
Q2 | $2.59M | Buy |
9,102
+2,373
| +35% | +$706K | ﹤0.01% | 647 |
|
|
2023
Q1 | $1.87M | Buy |
6,729
+268
| +4% | +$74.2K | ﹤0.01% | 704 |
|
|
2022
Q4 | $1.79M | Buy |
6,461
+11
| +0.2% | +$3.11K | ﹤0.01% | 693 |
|
|
2022
Q3 | $1.72M | Buy |
6,450
+71
| +1% | +$15.1K | ﹤0.01% | 667 |
|
|
2022
Q2 | $1.3M | Buy |
6,379
+516
| +9% | +$105K | ﹤0.01% | 741 |
|
|
2022
Q1 | $1.23M | Buy |
5,863
+1,111
| +23% | +$242K | ﹤0.01% | 780 |
|
|
2021
Q4 | $1.14M | Sell |
4,752
-541
| -10% | -$139K | ﹤0.01% | 779 |
|
|
2021
Q3 | $1.5M | Sell |
5,293
-37
| -0.7% | -$12.1K | ﹤0.01% | 645 |
|
|
2021
Q2 | $1.85M | Sell |
5,330
-9,774
| -65% | -$2.96M | ﹤0.01% | 579 |
|
|
2021
Q1 | $4.23M | Buy |
15,104
+2,531
| +20% | +$683K | 0.01% | 372 |
|
|
2020
Q4 | $3.08M | Buy |
12,573
+1,725
| +16% | +$445K | 0.01% | 398 |
|
|
2020
Q3 | $3.08M | Buy |
10,848
+3,507
| +48% | +$978K | 0.01% | 360 |
|
|
2020
Q2 | $1.96M | Buy |
7,341
+2,505
| +52% | +$753K | 0.01% | 410 |
|
|
2020
Q1 | $1.53M | Sell |
4,836
-303
| -6% | -$92K | 0.01% | 408 |
|
|
2019
Q4 | $1.53M | Sell |
5,139
-2,101
| -29% | -$583K | 0.01% | 441 |
|
|
2019
Q3 | $1.69M | Sell |
7,240
-568
| -7% | -$132K | 0.01% | 408 |
|
|
2019
Q2 | $1.83M | Sell |
7,808
-3,095
| -28% | -$715K | 0.01% | 385 |
|
|
2019
Q1 | $2.58M | Sell |
10,903
-20,428
| -65% | -$6.43M | 0.01% | 327 |
|
|
2018
Q4 | $9.43M | Buy |
31,331
+65
| +0.2% | +$20.7K | 0.05% | 169 |
|
|
2018
Q3 | $11M | Buy |
31,266
+700
| +2% | +$241K | 0.06% | 162 |
|
|
2018
Q2 | $8.87M | Sell |
30,566
-219
| -0.7% | -$61.6K | 0.05% | 174 |
|
|
2018
Q1 | $8.43M | Buy |
30,785
+627
| +2% | +$195K | 0.05% | 171 |
|
|
2017
Q4 | $9.61M | Buy |
30,158
+9
| +0% | +$2.89K | 0.06% | 155 |
|
|
2017
Q3 | $9.44M | Buy |
30,149
+1,954
| +7% | +$579K | 0.07% | 149 |
|
|
2017
Q2 | $7.65M | Buy |
28,195
+2,173
| +8% | +$575K | 0.06% | 156 |
|
|
2017
Q1 | $7.12M | Buy |
26,022
+12,932
| +99% | +$3.66M | 0.06% | 151 |
|
|
2016
Q4 | $3.71M | Buy |
13,090
+6,252
| +91% | +$1.85M | 0.04% | 193 |
|
|
2016
Q3 | $2.14M | Buy |
6,838
+2,334
| +52% | +$691K | 0.14% | 95 |
|
|
2016
Q2 | $1.09M | Buy |
4,504
+1,220
| +37% | +$322K | 0.02% | 297 |
|
|
2016
Q1 | $855K | Buy |
3,284
+279
| +9% | +$73.7K | 0.01% | 303 |
|
|
2015
Q4 | $921K | Buy |
3,005
+1,207
| +67% | +$347K | 0.02% | 270 |
|
|
2015
Q3 | $525K | Buy |
1,798
+69
| +4% | +$22.8K | 0.01% | 325 |
|
|
2015
Q2 | $698K | Buy |
1,729
+393
| +29% | +$158K | 0.02% | 283 |
|
|
2015
Q1 | $565K | Buy |
1,336
+668
| +100% | +$263K | 0.02% | 303 |
|
|
2014
Q4 | $227K | Buy |
668
+99
| +17% | +$32K | 0.01% | 406 |
|
|
2014
Q3 | $188K | Sell |
569
-75
| -12% | -$24.7K | 0.01% | 413 |
|
|
2014
Q2 | $203K | Buy |
644
+20
| +3% | +$6.02K | 0.01% | 392 |
|
|
2014
Q1 | $191K | Sell |
624
-227
| -27% | -$72.1K | 0.01% | 392 |
|
|
2013
Q4 | $238K | Buy |
851
+170
| +25% | +$44K | 0.01% | 355 |
|
|
2013
Q3 | $164K | Buy |
681
+73
| +12% | +$16.3K | 0.01% | 389 |
|
|
2013
Q2 | $130K | Buy |
+608
| New | +$130K | 0.01% | 399 |
|
Other funds holding BIIB
VCM
VPM
Northwestern Mutual Wealth Management's BIIB Position: Q1 2026 in Review
Northwestern Mutual Wealth Management increased its Biogen (BIIB) stake by 7% in Q1 2026, buying an estimated $85.1K and bringing the position to 7,046 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1252.
Northwestern Mutual Wealth Management first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $11M in Q3 2018. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Northwestern Mutual Wealth Management held 7,046 shares of Biogen worth $1.29M as of Q1 2026.
- Northwestern Mutual Wealth Management bought 462 Biogen shares in Q1 2026, an estimated $85.1K.
- Biogen made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #1252 holding.
- Northwestern Mutual Wealth Management first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Northwestern Mutual Wealth Management's Biogen position peaked at $11M in Q3 2018.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.